CELLULAR BIOMEDICINE GROUP, INC. Increase (Decrease) in Other Receivables
CELLULAR BIOMEDICINE GROUP, INC. reported Increase (Decrease) in Other Receivables of $150.22 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2020-02-28
- CELLULAR BIOMEDICINE GROUP, INC. increase (decrease) in other receivables for fiscal 2019 was $150.22K.
- CELLULAR BIOMEDICINE GROUP, INC. increase (decrease) in other receivables for fiscal 2018 was -$66.11K, a 114.13% decline from fiscal 2017.
- CELLULAR BIOMEDICINE GROUP, INC. increase (decrease) in other receivables for fiscal 2017 was $467.99K, a 198.70% increase from fiscal 2016.
- CELLULAR BIOMEDICINE GROUP, INC. increase (decrease) in other receivables for fiscal 2016 was $156.67K, a 9.02% increase from fiscal 2015.
| Period end | Increase (Decrease) in Other Receivables 12 month |
|---|---|
| 2019-12-31 | $150.22K 10-K · filed 2020-02-28 |
| 2018-12-31 | -$66.11K 10-K · filed 2020-02-28 |
| 2017-12-31 | $467.99K 10-K · filed 2020-02-28 |
| 2016-12-31 | $156.67K 10-K · filed 2019-02-19 |
| 2015-12-31 | $143.71K 10-K · filed 2018-03-05 |
| 2014-12-31 | $25.64K 10-K · filed 2017-03-13 |
| 2013-12-31 | -$50.16K 10-K · filed 2016-03-14 |